TrialBritish journal of clinical pharmacology2020

A large multicentre, randomized, double-blind, cross-over study in healthy volunteers to compare pharmacokinetics, pharmacodynamics and safety of a pegfilgrastim biosimilar with its US- and EU-reference biologics.

Anne Bellon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.